World's Best Scientists 2026 revealed!
Joseph Rubin

Joseph Rubin

D-Index & Metrics

Medicine

D-Index
74
Citations
24982
World Ranking
19316
National Ranking
9623

Overview

Joseph Rubin is a researcher affiliated with Mayo Clinic in the United States, specializing primarily in Medicine with a focus on endocrine and metabolic disorders as well as epidemiological studies. Their research covers clinical and translational aspects particularly related to thyroid cancer and neuroendocrine tumors.

The recent scientific contributions of Joseph Rubin include studies on the diagnosis and treatment of thyroid cancer. One notable publication is titled An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer, published in 2020 in the journal Thyroid. This study explores therapeutic options for a difficult-to-treat thyroid cancer subtype, expanding knowledge on targeted therapies.

Joseph Rubin collaborates frequently with several other researchers. Their most recurrent coauthors include:

  • Keith C. Bible
  • Michael E. Menefee
  • Chia-Chi Lin
  • Michael Millward
  • William J. Maples

The distribution of publication venues for their work appears concentrated, with the journal Thyroid hosting a notable portion of their research output.

Their main fields of study include:

  • Medicine

Within Medicine, their research has specialized subfields such as:

  • Endocrinology, Diabetes and Metabolism
  • Epidemiology

Joseph Rubin focuses on two main research topics:

  • Thyroid Cancer Diagnosis and Treatment
  • Neuroendocrine Tumor Research Advances

Best Publications

  • Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5‐fluorouracil), and high dose radiation + 5‐fluorouracil. The gastrointestinal tumor study group

    C. G. Moertel;S. Frytak;R. G. Hahn;M. J. O'Connell

  • Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue.

    Larry K. Kvols;Charles G. Moertel;Michael J. O'Connell;Allan J. Schutt

  • Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms

    Charles G. Moertel;Larry K. Kvols;Michael J. O'Connell;Joseph Rubin

  • Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival

    Thorvardur R. Halfdanarson;K. G. Rabe;J. Rubin;G. M. Petersen

  • Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.

    J A Laurie;C G Moertel;T R Fleming;H S Wieand

  • Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival.

    Juan M Sarmiento;Glenroy Heywood;Joseph Rubin;Duane M Ilstrup

  • High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison.

    Charles G. Moertel;Thomas R. Fleming;Edward T. Creagan;Joseph Rubin

  • Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial.

    Edward T. Creagan;Charles G. Moertel;Judith R. O'Fallon;Allan J. Schutt

  • Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study.

    Matthew P. Goetz;Matthew R. Callstrom;J. William Charboneau;Michael A. Farrell

  • Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study.

    Keith C Bible;Vera J Suman;Julian R Molina;Robert C Smallridge

  • A Comparison of Three Chemotherapeutic Regimens in the Treatment of Advanced Pancreatic and Gastric Carcinoma: Fluorouracil vs Fluorouracil and Doxorubicin vs Fluorouracil, Doxorubicin, and Mitomycin

    Stephen A. Cullinan;Charles G. Moertel;Thomas R. Fleming;Joseph R. Rubin

  • Intra-arterial Floxuridine vs Systemic Fluorouracil for Hepatic Metastases From Colorectal Cancer: A Randomized Trial

    J. Kirk Martin;Michael J. O'Connell;Harry S. Wieand;Robert J. Fitzgibbons

  • Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer.

    M J O'Connell;J A Laurie;M Kahn;R J Fitzgibbons

  • Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors

    Thorvardur R Halfdanarson;Joseph Rubin;Michael B Farnell;Clive S Grant

  • Octreotide Acetate Long-Acting Formulation Versus Open-Label Subcutaneous Octreotide Acetate in Malignant Carcinoid Syndrome

    Joseph Rubin;Jaffer Ajani;William Schirmer;Alan P. Venook

  • Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer.

    James N. Ingle;David L. Ahmann;Stephanie J. Green;John H. Edmonson

  • Hepatic Arterial Infusion of a Replication-selective Oncolytic Adenovirus (dl1520): Phase II Viral, Immunologic, and Clinical Endpoints

    Tony Reid;Eva Galanis;James Abbruzzese;Dan Sze

  • The management of patients with advanced carcinoid tumors and islet cell carcinomas

    Charles G. Moertel;C. Michael Johnson;Michael A. McKusick;J. Kirk Martin

  • Phase II Trial of Irinotecan in Patients With Metastatic Colorectal Carcinoma

    Henry C. Pitot;Donald B. Wender;Michael J. O'Connell;Georgene Schroeder

  • Painful Metastases Involving Bone: Feasibility of Percutaneous CT- and US-guided Radio-frequency Ablation

    Matthew R. Callstrom;J. William Charboneau;Matthew P. Goetz;Joseph Rubin

Frequent Co-Authors

Larry K. Kvols
Larry K. Kvols University of South Florida
James N. Ingle
James N. Ingle Mayo Clinic
Jeff A. Sloan
Jeff A. Sloan Mayo Clinic
Richard M. Goldberg
Richard M. Goldberg West Virginia University
Matthew P. Goetz
Matthew P. Goetz Mayo Clinic
Alex A. Adjei
Alex A. Adjei Cleveland Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a future in medicine but want flexible and affordable educational options, a range of online health degrees and career pathways are available. Those interested in pharmacy can explore the cheapest online pharmacy school programs, making it more accessible to enter this vital healthcare field.

For those focused on the administrative side of healthcare, pursuing an online mhi (Master of Health Information Management) degree can open doors to in-demand careers managing health data and systems.

Careers such as medical billing and coding are also in high demand and can be started quickly through specialized certificate or degree programs. Find out how much does it cost to become a medical coder and choose affordable online options to start working in healthcare without years of schooling.

Lastly, for nurses looking to advance, there are cheap online fnp programs (Family Nurse Practitioner), offering a pathway to higher responsibility roles with flexible study options.

Best Scientists Citing Joseph Rubin

Trending Scientists